Intended for healthcare professionals

Letters Profiteering from vaccine inequity

Profiteering from vaccine inequity: nudge pharma towards “doing well by doing good”

BMJ 2021; 374 doi: (Published 15 September 2021) Cite this as: BMJ 2021;374:n2255
  1. Helena Earl, emeritus professor of clinical cancer medicine
  1. Department of Oncology, University of Cambridge, Cambridge, UK
  1. hme22{at}

I read with interest your editorial about profiteering from vaccine inequity.1 Fortunately the UK government seems to have listened to views about prioritising vaccination of the world ahead of routine booster vaccinations this year. The benefits of booster vaccination to the “normal” population are marginal at best when compared with the benefits for all of us if we can …

View Full Text

Log in

Log in through your institution


* For online subscription